Procalcitonin-guided algorithm to reduce length of antibiotic therapy in patients with severe sepsis and septic shock

被引:62
|
作者
Hohn, Andreas [1 ]
Schroeder, Stefan [2 ]
Gehrt, Anna [3 ]
Bernhardt, Kathrin [3 ]
Bein, Berthold [4 ]
Wegscheider, Karl [5 ]
Hochreiter, Marcel [6 ]
机构
[1] Ruhr Univ Bochum, BG Univ Hosp Bergmannsheil, Dept Anaesthesiol Intens Care Palliat Care & Pain, D-44789 Bochum, Germany
[2] Hosp Duren Gem GmbH, Dept Anaesthesiol Intens Care Med & Pain Therapy, D-52351 Duren, Germany
[3] West Coast Hosp, Dept Anesthesiol & Intens Care Med, D-25746 Heide, Germany
[4] Univ Hosp Schleswig Holstein, Dept Anesthesiol & Intens Care Med, D-24105 Kiel, Germany
[5] Univ Med Ctr Hamburg Eppendorf, Dept Med Biometry & Epidemiol, D-20246 Hamburg, Germany
[6] Univ Heidelberg Hosp, Dept Anesthesiol, D-69120 Heidelberg, Germany
关键词
Procalcitonin; Sepsis; Economical outcomes; Intensive care; RESPIRATORY-TRACT INFECTIONS; VENTILATOR-ASSOCIATED PNEUMONIA; INTENSIVE-CARE PATIENTS; ANTIMICROBIAL RESISTANCE; DISEASES-SOCIETY; CONTROLLED-TRIAL; DURATION; GUIDELINES; EPIDEMIOLOGY; INITIATION;
D O I
10.1186/1471-2334-13-158
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Procalcitonin (PCT)-protocols to guide antibiotic treatment in severe infections are known to be effective. But less is known about the long-term effects of such protocols on antibiotic consumption under real life conditions. This retrospective study analyses the effects on antibiotic use in patients with severe sepsis and septic shock after implementation of a PCT-protocol. Methods: We conducted a retrospective ICU-database search for adult patients between 2005 and 2009 with sepsis and organ dysfunction who where treated accordingly to a PCT-guided algorithm as follows: Daily measurements of PCT (BRAHMS PCT LIA (R); BRAHMS Aktiengesellschaft, Hennigsdorf, Germany). Antibiotic therapy was discontinued if 1) clinical signs and symptoms of infection improved and PCT decreased to <= 1 ng/ml, or 2) if the PCT value was >1 ng/ml, but had dropped to 25-35% of the initial value within three days. The primary outcome parameters were: antibiotic days on ICU, ICU re-infection rate, 28-day mortality rate, length of stay (LOS) in ICU, mean antibiotic costs (per patient) and ventilation hours. Data from 141 patients were included in our study. Primary outcome parameters were analysed using covariance analyses (ANCOVA) to control for effects by gender, age, SAPS II, APACHE II and effective cost weight. Results: From baseline data of 2005, duration of antibiotic therapy was reduced by an average of 1.0 day per year from 14.3 +/- 1.2 to 9.0 +/- 1.7 days in 2009 (p=0.02). ICU re-infection rate was decreased by yearly 35.1% (95% CI -53 to -8.5; p=0.014) just as ventilation hours by 42 hours per year (95% CI -72.6 to -11.4; p=0.008). ICU-LOS was reduced by 2.7 days per year (p<0.001). Trends towards an average yearly reduction of 28-day mortality by -22.4% (95% CI -44.3 to 8.1; p=0.133) and mean cost for antibiotic therapy/patient by -14.3 Euro (95% CI -55.7 to 27.1) did not reach statistical significance. Conclusions: In a real-life clinical setting, implementation of a PCT-protocol was associated with a reduced duration of antibiotic therapy in septic ICU patients without compromising clinical or economical outcomes.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Adhering to the procalcitonin algorithm allows antibiotic therapy to be shortened in patients with ventilator-associated pneumonia
    Beye, Florence
    Vigneron, Clara
    Dargent, Auguste
    Prin, Sebastien
    Andreu, Pascal
    Large, Audrey
    Quenot, Jean-Pierre
    Bador, Julien
    Bruyere, Remi
    Charles, Pierre-Emmanuel
    JOURNAL OF CRITICAL CARE, 2019, 53 : 125 - 131
  • [42] An ESICM systematic review and meta-analysis of procalcitonin-guided antibiotic therapy algorithms in adult critically ill patients
    Dimitrios K. Matthaiou
    Georgia Ntani
    Marina Kontogiorgi
    Garyfallia Poulakou
    Apostolos Armaganidis
    George Dimopoulos
    Intensive Care Medicine, 2012, 38 : 940 - 949
  • [43] Delays in Administration of the Second Antibiotic Dose in Patients With Severe Sepsis and Septic Shock
    Randolph, Jana L.
    Chan, Kin
    Albright, Amanda
    Chen, Aleda
    HOSPITAL PHARMACY, 2021, 56 (04) : 247 - 251
  • [44] Corticosteroid therapy in patients with severe sepsis and septic shock
    Keh, D
    Goodman, S
    Sprung, CL
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2004, 25 (06) : 713 - 719
  • [45] Procalcitonin-Guided Antibiotic Prescription in Patients With COVID-19 A Multicenter Observational Cohort Study
    Hessels, Lisa M.
    Speksnijder, Esther
    Paternotte, Nienke
    van Huisstede, Astrid
    Thijs, Willemien
    Scheer, Margot
    van der Steen-Dieperink, Marielle
    Knarren, Lieve
    van Den Bergh, Joop P.
    Winckers, Kristien
    Henry, Ronald
    Simsek, Suat
    CHEST, 2023, 164 (03) : 596 - 605
  • [46] The Prevalence and Clinical Significance of Low Procalcitonin Levels Among Patients With Severe Sepsis or Septic Shock in the Emergency Department
    Choe, Eun A.
    Shin, Tae Gun
    Jo, Ik Joon
    Hwang, Sung Yeon
    Lee, Tae Rim
    Cha, Won Chul
    Sim, Min Seob
    SHOCK, 2016, 46 (01): : 37 - 43
  • [47] A new diagnostic and severity marker in patients with SIRS, sepsis, severe sepsis and septic shock; procalcitonin
    S Çelebi
    P Ergin Özcan
    S Tugrul
    N Çakar
    F Esen
    Critical Care, 4 (Suppl 1):
  • [48] Is Procalcitonin Biomarker-Guided Antibiotic Therapy a Cost-Effective Approach to Reduce Antibiotic Resistant and Clostridium difficile Infections in Hospitalized Patients?
    Steuten, Lotte
    Mewes, Janne
    Lepage-Nefkens, Isabelle
    Vrijhoef, Hubertus
    OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY, 2018, 22 (09) : 616 - 625
  • [49] Is Procalcitonin-Guided Antimicrobial Use Cost-Effective in Adult Patients with Suspected Bacterial Infection and Sepsis?
    Harrison, Michelle
    Collins, Curtis D.
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2015, 36 (03): : 265 - 272
  • [50] Procalcitonin for early diagnosis and differentiation of SIRS, sepsis, severe sepsis, and septic shock
    F. M. Brunkhorst
    K. Wegscheider
    Z. F. Forycki
    R. Brunkhorst
    Intensive Care Medicine, 2000, 26 : S148 - S152